The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.
Open accessAbstract
Epstein-Barr virus (EBV) efficiently transforms B lymphocytes to perpetual proliferation. The EBV laboratory strain P3HR-1 is transformation-incompetent and lacks a DNA segment that includes the EBV nuclear antigen 2 (EBNA-2) gene and a portion of the EBNA leader protein (EBNA-LP) gene. These two genes are expressed in transformed B lymphocytes. Recombinant transformation-competent EBVs were produced by transfecting P3HR-1-infected cells with a cosmid containing the DNA deleted in P3HR-1. Deletion of 105 nucleotides from the middle of the EBNA-2 gene had no discernible affect on transformation. Two larger EBNA-2 deletions abolished transformation but did not affect EBNA-2 nuclear localization. Two naturally occurring EBV variants (EBV types 1 and 2) differ extensively in their growth-transformation phenotype and in their EBNA-LP, EBNA-2, and EBNA-3A, -3B, and -3C genes. Recombinant P3HR-1 carrying EBV-1 EBNA-2 has many of the EBV-1 in vitro growth-transforming effects; recombinant P3HR-1, isogenic except for EBV-2 EBNA-2, has many of the EBV-2 growth-transforming effects including slow emergence of transformants, growth in tight clumps with few surrounding viable cells, and early sensitivity to dilution with fresh medium. Thus, EBNA-2 is an essential molecule in lymphocyte growth transformation by EBV and a major determinant of the differences between EBV-1 and EBV-2 in lymphocyte growth transformation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA sequence and expression of the B95-8 Epstein—Barr virus genome
Baer, R., Bankier, A. T., Biggin, M. D., Deininger, P. L., Farrell, P. J., Gibson, T. J., Hatfull, G., Hudson, G. S., Satchwell, S. C., Séguin, C., et al. (1984) · Nature · doi:10.1038/310207a0 · Cited by 2,053
An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells
Wang, D., Liebowitz, D., & Kieff, E. (1985) · Cell · doi:10.1016/0092-8674(85)90256-9 · Cited by 1,225
Self-citationYoung, L., Alfieri, C., Hennessy, K., Evans, H., O'Hara, C., Anderson, K. C., Ritz, J., Shapiro, R. S., Rickinson, A., Kieff, E., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198910193211604 · Cited by 749
Self-citationGenetic analysis of immortalizing functions of Epstein–Barr virus in human B lymphocytes
Hammerschmidt, W., & Sugden, B. (1989) · Nature · doi:10.1038/340393a0 · Cited by 541
Phelps, W. C., Yee, C. L., Münger, K., & Howley, P. M. (1988) · Cell · doi:10.1016/0092-8674(88)90570-3 · Cited by 509
Rapid and easy sequencing of large linear double-stranded DNA and supercoiled plasmid DNA
Zagursky, R. J., Baumeister, K., Lomax, N., & Berman, M. L. (1985) · Gene Analysis Techniques · doi:10.1016/0735-0651(85)90011-1 · Cited by 396
Wang, F., Gregory, C. D., Rowe, M., Rickinson, A. B., Wang, D., Birkenbach, M., Kikutani, H., Kishimoto, T., & Kieff, E. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.10.3452 · Cited by 388
Self-citationWang, D., Liebowitz, D., Wang, F., Gregory, C. D., Rickinson, A. B., Larson, R. A., Springer, T. A., & Kieff, E. D. (1988) · Journal of Virology · doi:10.1128/jvi.62.11.4173-4184.1988 · Cited by 384
Self-citationU2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2.
Dambaugh, T., Hennessy, K., Chamnankit, L., & Kieff, E. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.23.7632 · Cited by 383
Self-citationRickinson, A. B., Young, L. S., & Rowe, M. (1987) · Journal of Virology · doi:10.1128/jvi.61.5.1310-1317.1987 · Cited by 369
Cited by
Epstein–Barr virus: 40 years on
Young, L. S., & Rickinson, A. B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1452 · Cited by 2,227
Rooney, C. M., Ng, C. Y. C., Loftin, S., Smith, C. A., Li, C., Krance, R. A., Brenner, M. K., Heslop, H. E., Rooney, C. M., Brenner, M. K., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91150-2 · Cited by 1,173
Mosialos, G., Birkenbacht, M., Yalamanchill, R., Van Arsdale, T., Ware, C., & Kleff, E. (1995) · Cell · doi:10.1016/0092-8674(95)90489-1 · Cited by 980
Thompson, M. P., & Kurzrock, R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0670-3 · Cited by 786
Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.
Kaye, K. M., Izumi, K. M., & Kieff, E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.9150 · Cited by 762
Self-citationThe Notch signaling pathway: Transcriptional regulation at Notch target genes
Borggrefe, T., & Oswald, F. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-8668-7 · Cited by 661
Wang, F., Gregory, C., Sample, C., Rowe, M., Liebowitz, D., Murray, R., Rickinson, A., & Kieff, E. (1990) · Journal of Virology · doi:10.1128/jvi.64.5.2309-2318.1990 · Cited by 566
Self-citationSPECTRUM OF EPSTEIN-BARR VIRUS–ASSOCIATED DISEASES
Kutok, J. L., & Wang, F. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100209 · Cited by 493
Self-citationKilger, E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1700 · Cited by 483
Propagation and recovery of intact, infectious Epstein–Barr virus from prokaryotic to human cells
Delecluse, H.-J., Hilsendegen, T., Pich, D., Zeidler, R., & Hammerschmidt, W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8245 · Cited by 467
Mediation of Epstein-Barr Virus EBNA2 Transactivation by Recombination Signal-Binding Protein J κ
Henkel, T., Ling, P. D., Hayward, S. D., & Peterson, M. G. (1994) · Science · doi:10.1126/science.8016657 · Cited by 455
Hsieh, J. J.-D., Henkel, T., Salmon, P., Robey, E., Peterson, M. G., & Hayward, S. D. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.952 · Cited by 451
Epstein-Barr Virus Infections: Biology, Pathogenesis, and Management
Straus, S. E., Cohen, J. I., Tosato, G., & Meier, J. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-1-199301010-00009 · Cited by 414
Self-citationIzumi, K. M., & Kieff, E. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12592 · Cited by 394
Self-citationTomkinson, B., Robertson, E., & Kieff, E. (1993) · Journal of Virology · doi:10.1128/jvi.67.4.2014-2025.1993 · Cited by 388
Self-citationEpstein–Barr virus latent genes
Kang, M.-S., & Kieff, E. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.84 · Cited by 361
Self-citationGrossman, S. R., Johannsen, E., Tong, X., Yalamanchili, R., & Kieff, E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7568 · Cited by 345
Self-citationExpression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice.
Wilson, J. B., Bell, J. L., & Levine, A. J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00674.x · Cited by 334
Miller, C. L., Burkhardt, A. L., Lee, J. H., Stealey, B., Longnecker, R., Bolen, J. B., & Kieff, E. (1995) · Immunity · doi:10.1016/s1074-7613(95)80040-9 · Cited by 320
Self-citationKieser, A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.21.6478 · Cited by 319
Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1
Wang, F., Tsang, S. F., Kurilla, M. G., Cohen, J. I., & Kieff, E. (1990) · Journal of Virology · doi:10.1128/jvi.64.7.3407-3416.1990 · Cited by 303
Self-citationMasking of the CBF1/RBPJ κ Transcriptional Repression Domain by Epstein-Barr Virus EBNA2
Hsieh, J. J.-D., & Hayward, S. D. (1995) · Science · doi:10.1126/science.7725102 · Cited by 293
The Proto-Oncogene c- myc Is a Direct Target Gene of Epstein-Barr Virus Nuclear Antigen 2
Kaiser, C., Laux, G., Eick, D., Jochner, N., Bornkamm, G. W., & Kempkes, B. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.4481-4484.1999 · Cited by 273
Epstein-Barr Virus Provides a New Paradigm: A Requirement for the Immediate Inhibition of Apoptosis
Altmann, M., & Hammerschmidt, W. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030404 · Cited by 266
Kaymaz, Y., Oduor, C. I., Yu, H., Otieno, J. A., Ong'echa, J. M., Moormann, A. M., & Bailey, J. A. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0305 · Cited by 120
Liang, J., Zhou, H., Gerdt, C., Tan, M., Colson, T., Kaye, K. M., Kieff, E., & Zhao, B. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616697113 · Cited by 88
Self-citationYang, X., He, Z., Xin, B., & Cao, L. (2000) · Oncogene · doi:10.1038/sj.onc.1203515 · Cited by 71
Immortalizing genes of Epstein-Barr virus
Middleton, T., Gahn, T. A., Martin, J. M., & Sugden, B. (1991) · Advances in Virus Research · doi:10.1016/s0065-3527(08)60276-6 · Cited by 42
Metadata
- Authors
- Cohen, J. I., Wang, F., Mannick, J., & Kieff, E.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1989-12
- Volume
- 86
- Issue
- 23
- Pages
- 9558-9562
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1985082049
- Cited by
- 483
- References
- 20
- FWCI
- 8.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.